FLC Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Buy
4,884
+1,540
+46% +$124K 0.06% 158
2026
Q1
$290K Sell
3,344
-2
-0.1% -$192 0.05% 176
2025
Q4
$321K Sell
3,346
-365
-10% -$35.5K 0.06% 158
2025
Q3
$353K Hold
3,711
0.07% 144
2025
Q2
$323K Sell
3,711
-798
-18% -$67.7K 0.07% 148
2025
Q1
$405K Buy
4,509
+400
+10% +$35.8K 0.09% 124
2024
Q4
$328K Hold
4,109
0.08% 131
2024
Q3
$370K Sell
4,109
-125
-3% -$10.5K 0.09% 123
2024
Q2
$333K Buy
4,234
+365
+9% +$29.9K 0.08% 122
2024
Q1
$337K Hold
3,869
0.09% 115
2023
Q4
$319K Buy
+3,869
New +$295K 0.09% 119
2023
Q3
Sell
-2,348
Closed -$207K 148
2023
Q2
$207K Buy
+2,348
New +$202K 0.06% 145
2022
Q4
Sell
-3,531
Closed -$285K 167
2022
Q3
$285K Buy
+3,531
New +$317K 0.1% 128
2022
Q2
Sell
-1,980
Closed -$220K 160
2022
Q1
$220K Buy
+1,980
New +$209K 0.06% 155
2021
Q4
Sell
-2,170
Closed -$272K 175
2021
Q3
$272K Hold
2,170
0.08% 145
2021
Q2
$269K Buy
2,170
+50
+2% +$6.28K 0.08% 148
2021
Q1
$250K Hold
2,120
0.08% 144
2020
Q4
$248K Sell
2,120
-175
-8% -$19.3K 0.08% 130
2020
Q3
$250K Hold
2,295
0.09% 116
2020
Q2
$214K Sell
2,295
-1,015
-31% -$97.3K 0.08% 111
2020
Q1
$285K Buy
3,310
+399
+14% +$42.4K 0.13% 83
2019
Q4
$330K Hold
2,911
0.13% 80
2019
Q3
$316K Hold
2,911
0.13% 85
2019
Q2
$285K Buy
2,911
+601
+26% +$54.9K 0.12% 95
2019
Q1
$210K Buy
+2,310
New +$207K 0.1% 105

Other funds holding MDT

FLC Capital Advisors's MDT Position: Q2 2026 in Review

FLC Capital Advisors increased its Medtronic (MDT) stake by 46% in Q2 2026, buying an estimated $124K and bringing the position to 4,884 shares worth $382K. The position accounts for 0.06% of the portfolio, ranked #158.

FLC Capital Advisors first reported a position in MDT in Q1 2019 and has held it in 25 quarters since. The position peaked at $405K in Q1 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • FLC Capital Advisors held 4,884 shares of Medtronic worth $382K as of Q2 2026.
  • FLC Capital Advisors bought 1,540 Medtronic shares in Q2 2026, an estimated $124K.
  • Medtronic made up 0.06% of FLC Capital Advisors's portfolio in Q2 2026, its #158 holding.
  • FLC Capital Advisors first reported a position in Medtronic in Q1 2019 and has held it in 25 quarters since.
  • FLC Capital Advisors's Medtronic position peaked at $405K in Q1 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.